mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.002 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.002 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.003 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.004 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.006 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |